Tejnaksh Healthcare Ltd
Tejnaksh Healthcare Limited is engaged in the business of providing hospital and healthcare services in Maharashtra with focus on clinical services, diagnostic facilities, and research. [1]
- Market Cap ₹ 49.4 Cr.
- Current Price ₹ 24.3
- High / Low ₹ 39.0 / 22.9
- Stock P/E 43.3
- Book Value ₹ 10.6
- Dividend Yield 0.00 %
- ROCE 9.56 %
- ROE 6.81 %
- Face Value ₹ 5.00
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -3.16% over past five years.
- Company has a low return on equity of 10.9% over last 3 years.
- Debtor days have increased from 33.6 to 64.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1.30 | 1.14 | 1.44 | 2.01 | 4.75 | 6.53 | 8.62 | 13.96 | 11.50 | 8.56 | 8.12 | 7.34 | 7.73 | |
0.78 | 0.55 | 0.49 | 1.04 | 2.45 | 3.67 | 4.37 | 10.34 | 7.93 | 4.96 | 3.76 | 4.21 | 4.88 | |
Operating Profit | 0.52 | 0.59 | 0.95 | 0.97 | 2.30 | 2.86 | 4.25 | 3.62 | 3.57 | 3.60 | 4.36 | 3.13 | 2.85 |
OPM % | 40.00% | 51.75% | 65.97% | 48.26% | 48.42% | 43.80% | 49.30% | 25.93% | 31.04% | 42.06% | 53.69% | 42.64% | 36.87% |
0.02 | 0.00 | 0.01 | 0.04 | 0.03 | 0.20 | 0.43 | 1.42 | 0.48 | 0.14 | 0.08 | 0.24 | 0.32 | |
Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | 0.96 | 0.77 | 0.80 | 0.54 | 0.48 | 0.62 | 0.72 |
Depreciation | 0.10 | 0.11 | 0.11 | 0.14 | 0.21 | 0.34 | 0.44 | 0.52 | 0.59 | 0.61 | 0.59 | 0.79 | 0.80 |
Profit before tax | 0.43 | 0.48 | 0.85 | 0.87 | 2.12 | 2.53 | 3.28 | 3.75 | 2.66 | 2.59 | 3.37 | 1.96 | 1.65 |
Tax % | 32.56% | 35.42% | 32.94% | 32.18% | 37.74% | 33.20% | 26.22% | 28.27% | 27.44% | 22.39% | 25.22% | 30.10% | |
0.30 | 0.31 | 0.57 | 0.60 | 1.32 | 1.69 | 2.43 | 2.69 | 1.92 | 2.00 | 2.52 | 1.38 | 1.14 | |
EPS in Rs | 0.41 | 0.65 | 0.84 | 1.20 | 1.33 | 0.95 | 0.99 | 1.24 | 0.68 | 0.57 | |||
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 20% |
5 Years: | -3% |
3 Years: | -14% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 16% |
5 Years: | -11% |
3 Years: | -10% |
TTM: | -39% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -3% |
3 Years: | -10% |
1 Year: | -32% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 13% |
3 Years: | 11% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 0.80 | 1.10 | 2.21 | 2.21 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 | 10.16 |
Reserves | 1.00 | 1.31 | 1.88 | 1.69 | 5.14 | 5.73 | 8.19 | 2.93 | 4.85 | 6.87 | 9.40 | 10.79 | 11.45 |
0.37 | 0.36 | 0.47 | 0.00 | 0.00 | 6.39 | 7.64 | 6.33 | 7.25 | 4.93 | 7.03 | 6.45 | 5.61 | |
0.30 | 0.33 | 0.62 | 1.04 | 0.60 | 0.55 | 1.13 | 1.99 | 2.02 | 1.92 | 2.09 | 2.40 | 2.98 | |
Total Liabilities | 1.68 | 2.01 | 2.98 | 3.53 | 6.84 | 14.88 | 19.17 | 21.41 | 24.28 | 23.88 | 28.68 | 29.80 | 30.20 |
1.40 | 1.37 | 1.43 | 2.86 | 3.34 | 13.43 | 14.54 | 16.19 | 16.59 | 14.34 | 14.55 | 22.51 | 23.34 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.39 | 0.65 | 0.79 | 8.89 | 0.95 | 0.01 |
Investments | 0.00 | 0.00 | 0.00 | 0.01 | 2.59 | 0.07 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 | 1.06 |
0.28 | 0.64 | 1.55 | 0.65 | 0.91 | 1.38 | 3.57 | 3.77 | 5.98 | 7.69 | 4.18 | 5.28 | 5.79 | |
Total Assets | 1.68 | 2.01 | 2.98 | 3.53 | 6.84 | 14.88 | 19.17 | 21.41 | 24.28 | 23.88 | 28.68 | 29.80 | 30.20 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.09 | 0.11 | 0.08 | 1.71 | 3.67 | 1.78 | 3.88 | 3.15 | 1.00 | 0.84 | 9.13 | 1.90 | |
-0.31 | -0.08 | -0.17 | -1.59 | -3.26 | -7.91 | -2.59 | -1.49 | -1.16 | 1.56 | -10.40 | -0.98 | |
0.00 | -0.01 | 0.11 | -0.04 | -0.13 | 6.39 | -0.64 | -2.08 | 0.22 | -2.86 | 1.61 | -1.17 | |
Net Cash Flow | -0.22 | 0.02 | 0.02 | 0.08 | 0.29 | 0.26 | 0.64 | -0.42 | 0.06 | -0.47 | 0.35 | -0.25 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.75 | 16.82 | 15.78 | 20.23 | 64.65 |
Inventory Days | 98.06 | 86.45 | 126.74 | 182.50 | 340.67 | 251.90 | 142.64 | |||||
Days Payable | 114.40 | 134.47 | 177.43 | 143.79 | 129.78 | 77.11 | 117.47 | |||||
Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | -16.34 | -48.03 | -50.69 | 5.75 | 55.53 | 226.67 | 195.02 | 89.82 |
Working Capital Days | -2.81 | 102.46 | 240.80 | -5.45 | -1.54 | 19.56 | -5.93 | 24.58 | 105.37 | 9.81 | -13.93 | 57.68 |
ROCE % | 35.77% | 31.37% | 42.08% | 36.29% | 48.57% | 26.45% | 26.20% | 24.13% | 16.60% | 14.20% | 16.07% | 9.56% |
Documents
Announcements
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 19 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 19 Apr
- Yearly Compliance Certificate (Financial Year Ended On March 31St, 2024 17 Apr
- Submission Of Certificate Under Regulation 7(3) Of SEBI (LODR) Regulation, 2015 For The Year Ended On 31.03.2024 16 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
15 Apr - Find Compliance Certificate under Reg.74(5) of SEBI(DP)Regulation 2018.
Annual reports
Concalls
-
Feb 2018TranscriptNotesPPT
Services
Super Speciality Hospital: The Co runs the Institute of Urology, Dhule a super speciality hospital that provides a comprehensive range of services from consultations and investigation to treatment of various urological problems such as kidneys, ureter, bladder, prostate, and other genital organs. It provides Laser Prostatectomy, Endourology & LASER Treatment, Dialysis Unit, Clinical Nephrology etc.
Healthcare Equipments: The Co also sells Healthcare Equipments including Radiation Free PERC Simulator, PCNL Logic Simulator, Fluoroscopy Guided Simulator, Stone Manipulation Simulator etc.
Education Institute: The Co also operates its coaching facility in Dhule. The academy aims to coach 10+2, XI and XII students for NEET, AIPMT, JEE and allied entrances. [1]